Copyright 2009-2012 BioSignia┬«, All Rights Reserved   

BioSignia Scientific Advisory Board ´┐Ż October 27, 2011
BioSignia Scientific Advisory Board



William Castelli, M.D.,

 Physician; Framingham, MA, Harvard Medical School, Chair of the Nutrition Department Harvard Medical School; past Director of the Framingham Heart Study; renowned author, Good Fat, Bad Fat, Cholesterol Cures, How to Lower Your Cholesterol and Beat the Odds of a Heart Attack and others; speaker and lecturer; Doctor of Medicine, Surgery and Obstetrics, University of Louvain.


Guizhou Hu, M.D., Ph.D.

Epidemiologist; Durham, NC, Chief Science Officer, BioSignia, Inc.; M.D., Bejing Medical University, Ph.D., Cornell University; part of founding group of BioSignia; Developer of Synthesis Modeling and associated U.S. Patent; specialty in statistical modeling of healthcare data; recipient of Healthcare Innovator Award.


Colin Campbell, Ph.D.

Nutritional Biochemist; Ithaca, NY, Founder of BioSignia; Jacob Gould Schurman Professor Emeritus of Nutritional Biochemistry, Cornell University and Project Director of the China-Oxford-Cornell Diet and Health Project; author of the best-seller The China Study; M.S. and Ph.D. from Cornell University.


Caldwell Esselstyn, Jr., M.D.

Renowned surgeon, author and researcher, Cleveland, OH, specializing in prevention and reversal of heart disease; Olympic gold medalist; trained at Cleveland Clinic and St. George's Hospital, London; former Army Surgeon, recipient of the Bronze Star; graduate of Yale University, M.D. from Western Reserve University.


Lori Orlando, M.D. M.Ph.

Physician, Internal Medicine, Durham, NC; Clinical interests in women's health and preventive medicine, as part of annual comprehensive health examinations; clinical researcher, Duke Executive Health Program; M.D. from Tulane university School of Medicine.


Timothy Smith, M.S., Ph.D.

Clinical Biochemist, Chapel Hill, NC, advocate for primary prevention in clinical practice, Former President & CEO, BioSignia; current Assistant to the Chairman, BioSignia; part of founding group of BioSignia; M.S. in Microbiology; Ph.D., Biomedical Sciences, East Tennessee State University, James H. Quillen College of Medicine.


William Kraus, M.D.

Physician, Internal Medicine, Durham, NC Duke University Medical Center with clinical interests in cardiac rehabilitation and prevention, congestive heart failure, exercise physiology, genetics of cardiovascular disease and CHD; Duke University Medical Professor; clinical researcher, author; M.D., Duke University School of Medicine.

Michael Bryant, M.D.

Physician/General Surgeon, Fayetteville, NC; President of Doctors Direct Healthcare, President, Sandhills IPA; Advocate for prevention and control of chronic diseases; entrepreneur and visionary for preventive clinical care; Graduate of University of Louisville School of Medicine.

David Michael, M.D.

Physician, Internal Medicine, Greenville, NC; currently Head of Medical Informatics, East Carolina University Medical Center, specializes in applied prevention in clinical practice and EMR-based decision tools for clinical practice; M.D. from The Ohio State University School of Medicine.

Andrew Zhou, Ph.D.

Biostatistics, statistical sciences, University of Washington, Seattle; Professor of statistics; researcher, speaker and author; interests in diagnostic medicine, ROC methodology, Categorical data analysis, health services research, analysis of skewed data, causal inferences, analysis of observational studies, propensity-score methodology, evaluation of biomarkers and analysis of missing data; Ph.D. from The Ohio State University.





BioSignia, Inc. • 401 Harrison Oaks Blvd., Suite 120 • Cary, NC 27513 • (919) 933-2021 • (888) 324-6627